Exact Mass: 417.2012

Exact Mass Matches: 417.2012

Found 43 metabolites which its exact mass value is equals to given mass value 417.2012, within given mass tolerance error 0.0002 dalton. Try search metabolite list with more accurate mass tolerance error 4.0E-5 dalton.

Ala Ala Ala Trp

(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2-aminopropanamido]propanamido]propanamido]-3-(1H-indol-3-yl)propanoic acid

C20H27N5O5 (417.2012)

Ala Ala Trp Ala

(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2-aminopropanamido]propanamido]-3-(1H-indol-3-yl)propanamido]propanoic acid

C20H27N5O5 (417.2012)

Ala Trp Ala Ala

(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2-aminopropanamido]-3-(1H-indol-3-yl)propanamido]propanamido]propanoic acid

C20H27N5O5 (417.2012)

Gly Gly Val Trp

(2S)-2-[(2S)-2-[2-(2-aminoacetamido)acetamido]-3-methylbutanamido]-3-(1H-indol-3-yl)propanoic acid

C20H27N5O5 (417.2012)

Gly Gly Trp Val

(2S)-2-[(2S)-2-[2-(2-aminoacetamido)acetamido]-3-(1H-indol-3-yl)propanamido]-3-methylbutanoic acid

C20H27N5O5 (417.2012)

Gly Val Gly Trp

(2S)-2-{2-[(2S)-2-(2-aminoacetamido)-3-methylbutanamido]acetamido}-3-(1H-indol-3-yl)propanoic acid

C20H27N5O5 (417.2012)

Gly Val Trp Gly

2-[(2S)-2-[(2S)-2-(2-aminoacetamido)-3-methylbutanamido]-3-(1H-indol-3-yl)propanamido]acetic acid

C20H27N5O5 (417.2012)

Gly Trp Gly Val

(2S)-2-{2-[(2S)-2-(2-aminoacetamido)-3-(1H-indol-3-yl)propanamido]acetamido}-3-methylbutanoic acid

C20H27N5O5 (417.2012)

Gly Trp Val Gly

2-[(2S)-2-[(2S)-2-(2-aminoacetamido)-3-(1H-indol-3-yl)propanamido]-3-methylbutanamido]acetic acid

C20H27N5O5 (417.2012)

Val Trp Asn

C20H27N5O5 (417.2012)

Asn Val Trp

C20H27N5O5 (417.2012)

Val Gly Gly Trp

(2S)-2-(2-{2-[(2S)-2-amino-3-methylbutanamido]acetamido}acetamido)-3-(1H-indol-3-yl)propanoic acid

C20H27N5O5 (417.2012)

Val Gly Trp Gly

2-[(2S)-2-{2-[(2S)-2-amino-3-methylbutanamido]acetamido}-3-(1H-indol-3-yl)propanamido]acetic acid

C20H27N5O5 (417.2012)

Val Trp Gly Gly

2-{2-[(2S)-2-[(2S)-2-amino-3-methylbutanamido]-3-(1H-indol-3-yl)propanamido]acetamido}acetic acid

C20H27N5O5 (417.2012)

Trp Ala Ala Ala

(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-3-(1H-indol-3-yl)propanamido]propanamido]propanamido]propanoic acid

C20H27N5O5 (417.2012)

Trp Gly Gly Val

(2S)-2-(2-{2-[(2S)-2-amino-3-(1H-indol-3-yl)propanamido]acetamido}acetamido)-3-methylbutanoic acid

C20H27N5O5 (417.2012)

Trp Gly Val Gly

2-[(2S)-2-{2-[(2S)-2-amino-3-(1H-indol-3-yl)propanamido]acetamido}-3-methylbutanamido]acetic acid

C20H27N5O5 (417.2012)

Trp Val Gly Gly

2-{2-[(2S)-2-[(2S)-2-amino-3-(1H-indol-3-yl)propanamido]-3-methylbutanamido]acetamido}acetic acid

C20H27N5O5 (417.2012)

TEGASEROD MALEATE

C20H27N5O5 (417.2012)

D018377 - Neurotransmitter Agents > D018490 - Serotonin Agents > D017366 - Serotonin Receptor Agonists C78272 - Agent Affecting Nervous System > C66885 - Serotonin Antagonist Tegaserod maleate (SDZ-HTF-919) is an orally active serotonin receptor 4 (HTR4; 5-HT4R) agonist and a 5-HT2B receptor antagonist. Tegaserod maleate has pKis of 7.5, 8.4 and 7.0 for human recombinant 5-HT2A, 5-HT2B and 5-HT2C receptors, respectively. Tegaserod maleate causes tumor cell apoptosis, blunts PI3K/Akt/mTOR signaling and decreases S6 phosphorylation. Tegaserod maleate has anti-tumor activity and has the potential for irritable bowel syndrome (IBS) research[1][2][3].